These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1197917

  • 1. Reserpine and calcium: interaction at the injection site.
    Kaplanski J, Stoof JC.
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):331-8. PubMed ID: 1197917
    [Abstract] [Full Text] [Related]

  • 2. Prevention by calcium administration of reserpine action on rat brain noradrenaline stores: a reappraisal.
    Manara L, Cerletti C, Mennini T.
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):471-87. PubMed ID: 959653
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system toxicity of manganese. II: Cocaine or reserpine inhibit manganese concentration in the rat brain.
    Ingersoll RT, Montgomery EB, Aposhian HV.
    Neurotoxicology; 1999 Jul; 20(2-3):467-76. PubMed ID: 10385905
    [Abstract] [Full Text] [Related]

  • 4. Depletion and recovery of catecholamines in several organs of rats treated with reserpine.
    Martínez-Olivares R, Villanueva I, Racotta R, Piñón M.
    Auton Neurosci; 2006 Jul 30; 128(1-2):64-9. PubMed ID: 16723281
    [Abstract] [Full Text] [Related]

  • 5. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S.
    Biochem Pharmacol; 1975 Jul 15; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract] [Full Text] [Related]

  • 6. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM, Kuczenski R, Segal DS.
    J Pharmacol Exp Ther; 1995 Jul 15; 274(1):231-41. PubMed ID: 7616403
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators.
    Fabrazzo M, Costa E, Mocchetti I.
    Mol Pharmacol; 1991 Feb 15; 39(2):144-9. PubMed ID: 1996081
    [Abstract] [Full Text] [Related]

  • 8. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
    Watanabe S, Aono Y, Fusa K, Takada K, Saigusa T, Koshikawa N, Cools AR.
    Neuroscience; 2005 Feb 15; 136(1):251-7. PubMed ID: 16181742
    [Abstract] [Full Text] [Related]

  • 9. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 10. Effect of reserpine and triiodothyronine on myocardial lipoprotein lipase, metabolic rate and plasma free fatty acids in rats.
    Silverman LH, Beznak M, Kako KJ.
    Arch Int Pharmacodyn Ther; 1972 Oct 28; 199(2):368-75. PubMed ID: 5070648
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT, Hooth MJ, Lookingland KJ, Moore KE, Marks TA.
    Toxicol Appl Pharmacol; 1993 Nov 28; 123(1):26-33. PubMed ID: 8236258
    [Abstract] [Full Text] [Related]

  • 12. Acetylcholine-induced stimulation of catecholamine recovery in denervated rat adrenals after reserpine-induced depletion.
    Patrick RL, Kirshner N.
    Mol Pharmacol; 1971 Jul 28; 7(4):389-96. PubMed ID: 4398814
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of reserpine on the protective function of diazepam against hyperbaric oxygen-induced convulsions].
    Jin SY, Zhang QQ, Zhuang J.
    Zhongguo Yao Li Xue Bao; 1987 Sep 28; 8(5):403-5. PubMed ID: 3450174
    [No Abstract] [Full Text] [Related]

  • 14. Possible explanations for the antagonism by nicotine against reserpine-induced depletion of monoamines in mouse brain.
    Oishi R, Suemaru K, Furuno K, Gomita Y, Saeki K.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug 28; 348(2):154-7. PubMed ID: 8232594
    [Abstract] [Full Text] [Related]

  • 15. Possible mechanisms involved in the hyperthermic effect caused by reserpine after pretreatment with amphetamine or tranylcypromine in conscious rat.
    Cremades A, Jané F, Serrano JS, Milanés MV.
    Methods Find Exp Clin Pharmacol; 1982 Aug 28; 4(8):569-73. PubMed ID: 7169844
    [Abstract] [Full Text] [Related]

  • 16. [Use of reserpine in myocardial contraction studies].
    Spadaro J.
    Arq Bras Cardiol; 1975 Oct 28; 28(5):569-75. PubMed ID: 766737
    [No Abstract] [Full Text] [Related]

  • 17. [Some adrenolytics and the acid RNAse activity in mitochondria of large hemisphere tissue].
    Nechaeva GA, Shaliapina VG.
    Vopr Med Khim; 1969 Oct 28; 15(4):389-93. PubMed ID: 4390850
    [No Abstract] [Full Text] [Related]

  • 18. Role of calcium in the reserpine-induced cerebral monoamines depletion.
    Radouco-Thomas S, Tessier L, Lajeunesse N, Garcin F.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Aug 28; 5(1):5-11. PubMed ID: 5570063
    [No Abstract] [Full Text] [Related]

  • 19. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.
    Glowinski J, Axelrod J, Iversen LL.
    J Pharmacol Exp Ther; 1966 Jul 28; 153(1):30-41. PubMed ID: 4380692
    [No Abstract] [Full Text] [Related]

  • 20. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1992 Jan 28; 260(1):409-16. PubMed ID: 1530977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.